NBIX
NASDAQ
US
Neurocrine Biosciences, Inc. - Common Stock
$131,60
▼ $-0,96
(-0,72%)
Vol. 707K
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$14.1B
P/E
33,0
ROE
15,8%
Margine
16,0%
D/E
0,00
Beta
0,31
52W
$84–$160
Consenso Wall Street
36 analisti · Apr 202613
Acquisto forte
18
Compra
5
Mantieni
0
Vendi
0
Vendita forte
86,1%
Rating Compra
Grafico dei Prezzi
Titoli simili
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16,3
$19.4B
SMMT
Summit Therapeutics Inc
$13.0B
BBIO
BridgeBio Pharma Inc
$14.7B
MDGL
Madrigal Pharmaceuticals Inc
$13.2B
IONS
Ionis Pharmaceuticals Inc
$12.8B
EXEL
Exelixis Inc
P/E 17,3
$11.8B
BMRN
BioMarin Pharmaceutical Inc
P/E 21,9
$11.4B
PRAX
Praxis Precision Medicines Inc
$7.4B
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $1,92 | $1,48 | $-0,44 |
| Set 2025 | $1,62 | $2,04 | +$0,42 |
| Giu 2025 | $0,99 | $1,06 | +$0,07 |
| Mar 2025 | $0,56 | $0,08 | $-0,48 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 13.2% | 13.2% | 13.2% | 15.8% | 15.8% | 15.8% |
| P/E (TTM) | 35.71 | 37.70 | 39.76 | 33.36 | 35.38 | 33.04 |
| Net Margin | 15.6% | 13.9% | 13.9% | 15.9% | 15.9% | 15.9% |
| Gross Margin | 98.4% | 98.5% | 98.5% | 98.4% | 98.4% | 98.4% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.20 | 3.20 | 3.20 | 3.38 | 3.38 | 3.38 |
Rapporti chiave
ROA (TTM)
11,0%
P/S (TTM)
5,27
P/B
5,3
EPS (TTM)
$4,19
CF/Share
$2,11
Crescita ricavi 3A
+27,6%
52W High
$160,18
52W Low
$84,23
$84,23
Intervallo 52 settimane
$160,18
Як NBIX виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка NBIX vs аналоги Biotechnology
P/E
33,0
▲
76%
sopra
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
5,3
▼
59%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
5,3
▲
117%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість NBIX vs аналоги Biotechnology
ROE
15,8%
▲
124%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
16,0%
▲
106%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
98,4%
▲
25%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
11,0%
▲
124%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя NBIX vs аналоги Biotechnology
D/E ratio
0,0
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
3,4
▼
24%
sotto
peer
(4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,3
▼
68%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів NBIX
NBIX
Mediana peer
Industria
NBIX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
NBIX vs аналоги: ключові метрики
Segnali Correlati
Ultime notizie
Nessuna notizia correlata ancora